Nature. 1992 Oct 15;359(6396):563. doi: 10.1038/359563a0.
By charging drug companies 'user fees' that will be spent hiring new staff, the US Food and Drug Administration will reduce the time it takes to review new pharmaceuticals from an average of two years to one.
通过向制药公司收取“用户费”,这笔费用将用于招聘新员工,美国食品药品监督管理局将把审查新药品所需的时间从平均两年减少到一年。